PROVIDEAN REPRODUCTIVA
VACCINE FOR THE PREVENTION OF BOVINE REPRODUCTIVE DISEASES
SYNDROME: REPRODUCTIVE


Each dose of vaccine contains inactivated antigens: Clostridium botulinum type C toxoids (≥105 LD50%/dose), Clostridium botulinum type D (≥105 LD50%/dose), Adjuvant Pilatus GHA500®, Excipients q.s. to 5 ml.
Apply subcutaneously only. Shake frequently and before loading each syringe.
Cattle: 5 ml/dose.
Sheep: 2ml/dose.
Cattle: First vaccination: Animals should be vaccinated from 3 months of life onwards. In primo-vaccination, revaccinate 30 days after the first dose. Future applications: once a year. Pregnant females: Previously vaccinated animals: 1 dose 30 days before delivery. Animals not previously vaccinated: 1 dose 60 days before calving and another dose 30 days before calving.
Sheep: Primo-vaccinated animals: administer first dose at 2 months of age and a second dose after 30 days. Revaccinate annually.
Adult animals: administer 1 dose of 2 ml annually. The suggested scheme should be adapted to the recommendation of your veterinarian according to the particular needs of each region or farm.
125 ml (25 bovine doses /62 ovine doses).
250 ml (50 bovine doses /125 ovine doses).
Keep out of reach of children and domestic animals. Do not subject animals to stress or excessive work before and/or after vaccination. Do not administer in parasitized, malnourished, fatigued, or feverish animals, or animals on antibiotic and/or corticosteroid treatment.
Apply this product under the supervision of a veterinary professional. The product can generate a slight local reaction in the application site that disappears progressively. In isolated cases, the vaccine can produce anaphylactic shock, in which case apply epinephrine at 1‰.
Between 2º and 8º C. Do not freeze. Do not expose the product to heat or sunlight. Used containers should be discarded according to local legislation in force. In Uruguay: Used/expired containers should be deposited in storage centers.
© Tecnovax 2025
We are a biotechnology company with more than twenty years of experience in the development, production and global commercialization of new vaccines and immunotherapies to protect animal life and productivity.
We are a biotechnology company with more than twenty years of experience in the development, production and global commercialization of new vaccines and immunotherapies to protect animal life and productivity.